Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 175, Issue 1, Pages 68-78Publisher
WILEY
DOI: 10.1111/cei.12172
Keywords
human studies; immunodeficiency-primary; infections; intravenous immunoglobulin therapy (IVIG); therapy/immunotherapy
Categories
Funding
- Baxter
- CSL Behring
- Shire (UK)
- Grifols
- Biotest
- Octapharma
- BPL
- British Society for Immunology (BSI)
- Health Care Quality improvement programme (HQIP)
- European Society for Immune deficiency (ESID)
- NISCHR fellowship
Ask authors/readers for more resources
This report summarizes the establishment of the first national online registry of primary immune deficency in the United Kingdom, the United Kingdom Primary Immunodeficiency (UKPID Registry). This UKPID Registry is based on the European Society for Immune Deficiency (ESID) registry platform, hosted on servers at the Royal Free site of University College, London. It is accessible to users through the website of the United Kingdom Primary Immunodeficiency Network (www.ukpin.org.uk). Twenty-seven centres in the United Kingdom are actively contributing data, with an additional nine centres completing their ethical and governance approvals to participate. This indicates that 36 of 38 (95%) of recognized centres in the United Kingdom have engaged with this project. To date, 2229 patients have been enrolled, with a notable increasing rate of recruitment in the past 12 months. Data are presented on the range of diagnoses recorded, estimated minimum disease prevalence, geographical distribution of patients across the United Kingdom, age at presentation, diagnostic delay, treatment modalities used and evidence of their monitoring and effectiveness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available